Evidence map›Paper›PMID 31683510›Full record

ArticleMarine drugs2019

Improved Astaxanthin Production with

Nadja A Henke, Volker F Wendisch

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Efficient production of astaxanthin inSynthetic and systems biotechnology · 2025
    Article
  4. Article
  5. Response surface-based media optimization for astaxanthin production inFrontiers in bioengineering and biotechnology · 2025
    Article
  6. Article
  7. Review
  8. Promising non-model microbial cell factories obtained by genome reduction.Frontiers in bioengineering and biotechnology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Exploring the Potential ofFrontiers in bioengineering and biotechnology · 2021
    Article
  20. International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nadja A HenkeGenetics of Prokaryotes, Faculty of Biology & CeBiTec, Bielefeld University, P.O. Box 10 01 31, 33501 Bielefeld, Germany. n.henke@uni-bielefeld.de.ORCID 0000-0002-1304-6310
Volker F WendischGenetics of Prokaryotes, Faculty of Biology & CeBiTec, Bielefeld University, P.O. Box 10 01 31, 33501 Bielefeld, Germany. Volker.wendisch@uni-bielefeld.de.ORCID 0000-0003-3473-0012
Bielefeld University · DE

Funding

undefined <span style="color:gray;font-size:10px;">undefined</span> EFRE-0400184
6 · The paper itself

Abstract

Astaxanthin is one of the strongest natural antioxidants and a red pigment occurring in nature. This C40 carotenoid is used in a broad range of applications such as a colorant in the feed industry, an antioxidant in cosmetics or as a supplement in human nutrition. Natural astaxanthin is on the rise and, hence, alternative production systems are needed. The natural carotenoid producer

Indexed as

CarotenoidsCorynebacterium glutamicumGenetic EngineeringMembrane Fusion ProteinsMetabolic EngineeringMixed Function OxygenasesOxygenasesXanthophyllsastaxanthinebeta-carotene hydroxylasebeta-carotene ketolaseCarotenoidsMembrane Fusion ProteinsMixed Function OxygenasesOxygenasesXanthophyllsastaxanthinCorynebacterium glutamicumfusion proteinβ-carotene hydroxylaseβ-carotene ketolase

Identifiers

PMID31683510
PMCPMC6891673
OpenAlexW2982551297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.